Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Ocular Surface Inflammations With 1% Cyclosporine (Ikervis) Eye Drops

NCT07732855 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT07732855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07732855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Ocular Surface Inflammations With 1% Cyclosporine (Ikervis) Eye Drops
Lead sponsor
Semmelweis University
Phase
Observational
Overall status
Recruiting
Start date
June 10, 2025
Completion date
December 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blepharoconjunctivitis, conjunctivitis, allergic, ocular surface allergy